logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
D

Diana Romero

nature reviews clinical oncology

21H指数
293论文数
1.5K被引数
收录论文 203
发表时间
logo
Benefit with post-consolidation blinatumomab in newly diagnosed high-risk B-ALL新诊断高危B-ALL患者中巩固治疗后使用blinatumomab的益处
errNature Reviews Clinical Oncology
IF82.2
err2026-10-01
err0
PREAI
errDiana Romero
err分享
err收藏
Benefit from perioperative enfortumab vedotin–pembrolizumab in cisplatin-eligible MIBC顺铂适用性肌层浸润性膀胱癌患者从围手术期恩弗妥单抗维多汀–帕博利珠单抗中获益
errNature Reviews Clinical Oncology
IF82.2
err2026-08-04
err0
PREAI
errDiana Romero
err分享
err收藏
Neoadjuvant GOLP is effective in high-risk intrahepatic cholangiocarcinoma新辅助GOLP对高危肝内胆管癌有效
errNature Reviews Clinical Oncology
IF82.2
err2026-03-18
err0
PREAI
errDiana Romero
err分享
err收藏
Anbenitamab is a new second-line option in G/GEJ adenocarcinomaAnbenitamab是G/GEJ腺癌的新二线选择
errNature Reviews Clinical Oncology
IF82.2
err2026-01-28
err0
PREAI
errDiana Romero
err分享
err收藏
Base-edited CAR7 T cells are safe and efficacious in R/R T-ALL碱基编辑的CAR7 T细胞在R/R t-all中是安全有效的
errNature Reviews Clinical Oncology
IF82.2
err2026-01-06
err0
PREAI
errDiana Romero
err分享
err收藏
Sentinel lymph node biopsy improves surgical management of cervical cancer哨兵淋巴结活检改善了宫颈癌的手术治疗管理
errNature Reviews Clinical Oncology
IF82.2
err2025-11-17
err0
PREAI
errDiana Romero
err分享
err收藏
From the ESMO Congress 2025源自ESMO 2025年大会
errNature Reviews Clinical Oncology
IF82.2
err2025-11-04
err0
PREAI
errDiana Romero
err分享
err收藏
Climate Change and Assessing Thermal Comfort in Social Housing of Southeastern Mexico: A Prospective Study Using Machine Learning and Global Sensitivity Analysis气候变化与评估墨西哥东南部社会住房中的热舒适性：一项使用机器学习和全局敏感性分析的展望性研究
errSustainability 2025, Vol. 17, Page 9596
IF3.3
err2025-10-29
err0
errOAAI
errDiana Romero; Karla A. Torres; Joanny Gonzalez; A. J. Cetina-Quiñones; Cesar Acosta; M. Sadoqi; A. Bassam
err分享
err收藏
Iza-bren shows promise in recurrent or metastatic nasopharyngeal carcinomaIza-bren 在复发性或转移性鼻咽癌中显示出前景。
errNature Reviews Clinical Oncology
IF82.2
err2025-10-28
err0
errOAAI
errDiana Romero
err分享
err收藏
Belzutifan as a new option in pheochromocytomas and paragangliomasBelzutifan作为一种新的选择，用于嗜铬细胞瘤和副神经节瘤。
errNature Reviews Clinical Oncology
IF82.2
err2025-10-27
err0
PREAI
errDiana Romero
err分享
err收藏
Next-generation anti-Aβ antibodies show promise in a mouse model of Alzheimer disease下一代抗Aβ抗体在阿尔茨海默病小鼠模型中显示出前景。
errNature Biomedical Engineering
IF26.6
err2025-10-17
err0
PREAI
errDiana Romero
err分享
err收藏
MARIPOSA demonstrates overall survival benefit from amivantamab–lazertinibMARIPOSA试验表明，amivantamab–lazertinib可带来总生存获益。
errNature Reviews Clinical Oncology
IF82.2
err2025-09-23
err0
PREAI
errDiana Romero
err分享
err收藏
A new first-line option for advanced-stage anal squamous cell carcinoma晚期肛门鳞状细胞癌的新一线选择
errNature Reviews Clinical Oncology
IF82.2
err2025-07-01
err0
PREAI
errDiana Romero
err分享
err收藏
From ASCO 2025从ASCO 2025
errNature Reviews Clinical Oncology
IF82.2
err2025-06-23
err0
PREAI
errDiana Romero
err分享
err收藏
Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC在维持治疗中添加lurbinectedin可改善ES-SCLC的预后
errNature Reviews Clinical Oncology
IF82.2
err2025-06-12
err0
PREAI
errDiana Romero
err分享
err收藏
A new first-line standard-of-care for BRAFV600E-mutated mCRCBRAFV600E-mutated mCRC的新一线护理标准
errNature Reviews Clinical Oncology
IF82.2
err2025-06-12
err0
PREAI
errDiana Romero
err分享
err收藏
Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cellsCAR T细胞治疗后CD19淋巴瘤患者从huCAR19-IL18细胞中获益
errNature Reviews Clinical Oncology
IF82.2
err2025-05-23
err0
PREAI
errRomero, Diana
err分享
err收藏
Promising results with zongertinib in advanced-stage HER2-mutant NSCLCzongertinib在晚期HER2-mutant NSCLC中取得了令人鼓舞的结果
errNature Reviews Clinical Oncology
IF82.2
err2025-05-13
err0
PREAI
errRomero, Diana
err分享
err收藏
Zenocutuzumab shows efficacy in NRG1 fusion-positive solid tumoursZenocutuzumab 在 NRG1 融合阳性的实体瘤中显示出疗效。
errNATURE REVIEWS CLINICAL ONCOLOGY
IF82.2
err2025-02-20
err0
PREAI
errRomero, Diana
err分享
err收藏
Cadonilimab is efficacious in HER2-negative advanced-stage G/GEJ adenocarcinomasCadonilimab在HER2阴性的晚期胃/胃食管结合部腺癌中具有疗效。
errNATURE REVIEWS CLINICAL ONCOLOGY
IF82.2
err2025-02-07
err0
PREAI
errRomero, Diana
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jeffrey E. Gershenwald
H 指数: 102 · 论文数: 706
C
Christof Niehrs
H 指数: 83 · 论文数: 285
R
Rafael Simó
H 指数: 80 · 论文数: 630
J
Jarrod A. Marto
H 指数: 80 · 论文数: 325
C
Cristina Hernández
H 指数: 69 · 论文数: 435
查看更多